Oseltamivir News and Research

RSS
Tamiflu resistant flu on the rise: Study

Tamiflu resistant flu on the rise: Study

Plant world has great potential as a source of new medicines, says NYBG scientist

Plant world has great potential as a source of new medicines, says NYBG scientist

MRSA co-infection increases risk of flu-related mortality among children

MRSA co-infection increases risk of flu-related mortality among children

Romark announces results from NT-300 Phase 2B-3 trial on influenza

Romark announces results from NT-300 Phase 2B-3 trial on influenza

Something like 'Contagion' could happen for influenza

Something like 'Contagion' could happen for influenza

Tamiflu resistant flu found in Newcastle, Australia

Tamiflu resistant flu found in Newcastle, Australia

Nanoviricides lead anti-HIV candidate as good as HAART cocktail therapy

Nanoviricides lead anti-HIV candidate as good as HAART cocktail therapy

NanoViricides' anti-influenza drug development studies to be presented at TechConnect World 2011

NanoViricides' anti-influenza drug development studies to be presented at TechConnect World 2011

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

NanoViricides' FluCide drug candidate greatly reduces lung viral load in animals

New study sheds light on evolution of 2009 pandemic influenza A(H1N1) virus in Japan

New study sheds light on evolution of 2009 pandemic influenza A(H1N1) virus in Japan

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

Post-infection treatment with NanoViricides FluCide reduces lung lesions caused by lethal influenza infection

Post-infection treatment with NanoViricides FluCide reduces lung lesions caused by lethal influenza infection

Biota wins U.S. drug development contract for Laninamivir

Biota wins U.S. drug development contract for Laninamivir

NanoViricides reports improved efficacy with optimized FluCide nanoviricide drug candidates for influenza

NanoViricides reports improved efficacy with optimized FluCide nanoviricide drug candidates for influenza

Natco Pharma files ANDA with FDA for generic version of Tamiflu

Natco Pharma files ANDA with FDA for generic version of Tamiflu

Natco Pharma submits ANDA to FDA for generic version of Tamiflu 75 mg capsules

Natco Pharma submits ANDA to FDA for generic version of Tamiflu 75 mg capsules

BioCryst reports positive results from peramivir Phase 3 study in influenza

BioCryst reports positive results from peramivir Phase 3 study in influenza

Study highlights importance of independent evaluation of Tamiflu drug

Study highlights importance of independent evaluation of Tamiflu drug

Lung transplant saves economist from near-lethal bout of swine flu

Lung transplant saves economist from near-lethal bout of swine flu

Studies highlight need for new antiviral treatment options and strategies

Studies highlight need for new antiviral treatment options and strategies